Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
2010 · New England Journal of Medicine · 15K citations
https://doi.org/10.1056/nejmoa1003466
J
Joseph I. Clark
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
172
Papers
26.1K
Citations
46
h-index
90
i10-index
Joseph I. Clark is an academic researcher from Loyola University Medical Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Renal cell carcinoma treatment & CAR-T cell therapy research. The author has an h-index of 46, co-authored 147 publications.
ORCID: 0000-0002-0455-2625Papers by this author
worksThe Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
2013 · Nature Reviews Clinical Oncology · 197 citations
https://doi.org/10.1038/nrclinonc.2013.153
Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
1995 · PubMed · 140 citations
Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
2016 · Cancer Immunology Immunotherapy · 102 citations
https://doi.org/10.1007/s00262-016-1910-x
Clinical Development of 2B1, a Bispecific Murine Monoclonal Antibody Targeting c-erbB-2 and FcγRIII
1995 · Journal of Hematotherapy · 55 citations
https://doi.org/10.1089/scd.1.1995.4.453
A Prospective, Multicenter Analysis of Recurrence‐Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31‐<scp>GEP</scp>
2025 · Cancer Medicine · 2 citations
https://doi.org/10.1002/cam4.70839
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat